M&A deals, company strategies, pipeline updates and more
Follow our coverage of the 2019 J.P. Morgan Healthcare Conference in San Francisco
Factory-CRO Group, a medical device and in vitro diagnostics-focused CRO, has merged with U.S.-based Boston Biomedical Associates.
Schrödinger has snared $85 million in financing that will be used to support its computational platform and expand its pipeline.
A Cell and Gene Therapy Catapult study shows continued strong growth of advanced therapy medicinal products in the U.K.
Staff at the office will create tools that sponsors and the FDA can use to streamline the development and regulatory assessment of drugs.
MabSpace and HJB have formed a new biotherapeutics organization dubbed Transcenta Holding.
A political deadlock that led to a partial government shutdown before Christmas could take some of the shine off a golden year of FDA approvals.
Novotech adds Oracle’s Trial Management and Monitoring Cloud Service to support its work in the Asia-Pacific region.
WuXi AppTec shares firm some a week after the company debuted its IPO on the Hong Kong exchange.
Pharmaceutical Product Development is adding more punch to its therapeutics offerings with new leadership.
AstraZeneca is partnering with Cancer Research UK to debut a new research facility that will focus on using CRISPR and other functional genomics tech.